Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) EBT Margin (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed EBT Margin for 2 consecutive years, with 107118.75% as the latest value for Q3 2025.

  • Quarterly EBT Margin fell 10606715.0% to 107118.75% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 86379.69% through Dec 2025, down 8632051.0% year-over-year, with the annual reading at 86379.69% for FY2025, 8632051.0% down from the prior year.
  • EBT Margin hit 107118.75% in Q3 2025 for Connect Biopharma Holdings, down from 26758.33% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 61.69% in Q2 2024 to a low of 107118.75% in Q3 2025.